Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Nakakubo, Y. Hida, M. Miyamoto, H. Hashida, T. Oshikiri, Kentaro Kato, M. Suzuoki, K. Hiraoka, Tomoo Ito, T. Morikawa, S. Okushiba, S. Kondo, H. Katoh (2002)
The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus.Cancer letters, 177 1
S. Stilgenbauer, A. Schnaiter, P. Paschka, T. Zenz, M. Rossi, K. Döhner, A. Bühler, S. Böttcher, M. Ritgen, M. Kneba, D. Winkler, E. Tausch, Patrick Hoth, J. Edelmann, D. Mertens, L. Bullinger, M. Bergmann, Sabrina Kless, S. Mack, U. Jäger, N. Patten, Lin Wu, M. Wenger, G. Fingerle-Rowson, P. Lichter, M. Cazzola, C. Wendtner, A. Fink, K. Fischer, R. Busch, M. Hallek, H. Döhner (2012)
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.Blood, 123 21
H. Shi, Fu-jing Lv, Shengtao Zhu, Qing-gang Wang, Shu-tian Zhang (2011)
Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma.Cancer letters, 309 1
Xing Chen, Di Xie, Qi Zhao, Zhuhong You (2019)
MicroRNAs and complex diseases: from experimental results to computational modelsBriefings in Bioinformatics, 20
Ying Gao, N. Hu, Xiao-you Han, T. Ding, C. Giffen, A. Goldstein, P. Taylor (2011)
Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study.Cancer epidemiology, 35 6
S. Gan, X. Zhong, S. Xie, Su-mei Li, Hui Peng, F. Luo (2010)
Expression and significance of tumor drug resistance related proteins and beta-catenin in esophageal squamous cell carcinoma.Chinese journal of cancer, 29 3
Hongbao Cao, Junbo Duan, D. Lin, Y. Shugart, V. Calhoun, Yu-ping Wang (2014)
Sparse representation based biomarker selection for schizophrenia with integrated analysis of fMRI and SNPsNeuroImage, 102
(2014)
- modulating proteins and small molecules : candidate targets for cancer therapy
G Davis, S Mallat, M Avellaneda (1997)
Greedy adaptive approximationJ Constr Approx, 13
Simon Law, M. Fok, S. Cheng, John Wong (1992)
A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia.Surgery, gynecology & obstetrics, 175 2
Yuanbin Chen, Xiao-Yu Liao, Jiang-Bo Zhang, F. Wang, H. Qin, Lanjun Zhang, Y. Shugart, Y. Zeng, W. Jia (2017)
ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.International journal of oncology, 50 2
Zhaoting Yang, So-Young Yeo, Yong Yin, Zhen-hua Lin, Hak-Min Lee, Y. Xuan, Yan Cui, Seok-Hyung Kim (2016)
Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell CarcinomaPLoS ONE, 11
Zuxuan Shi, Yu Tang, Ke Li, Q. Fan (2015)
TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinomaTumor Biology, 36
Takuya Ando, H. Ishiguro, Y. Kuwabara, M. Kimura, A. Mitsui, N. Sugito, R. Mori, Ryo Ogawa, T. Katada, Y. Fujii (2008)
Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 21 1
Xuexiao Wang, Jiali Wang, Yunlong Jia, Yu Wang, Xiaonan Han, Y. Duan, W. Lv, M. Ma, Lihua Liu (2017)
Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transitionOncotarget, 8
Mike Lawrence, P. Stojanov, P. Polak, G. Kryukov, K. Cibulskis, A. Sivachenko, S. Carter, C. Stewart, C. Mermel, S. Roberts, Adam Kiezun, P. Hammerman, A. McKenna, Y. Drier, L. Zou, A. Ramos, T. Pugh, Nicolas Stransky, E. Helman, Jaegil Kim, C. Sougnez, L. Ambrogio, E. Nickerson, Erica Shefler, M. Cortés, D. Auclair, G. Saksena, Douglas Voet, M. Noble, D. Dicara, Pei Lin, Lee Lichtenstein, David Heiman, T. Fennell, M. Imieliński, Bryan Hernandez, Eran Hodis, S. Baca, A. Dulak, Jens Lohr, D. Landau, Catherine Wu, J. Meléndez-Zajgla, A. Hidalgo-Miranda, A. Koren, S. Mccarroll, J. Mora, B. Crompton, R. Onofrio, Melissa Parkin, W. Winckler, K. Ardlie, S. Gabriel, Charles Roberts, J. Biegel, K. Stegmaier, A. Bass, L. Garraway, M. Meyerson, T. Golub, D. Gordenin, S. Sunyaev, E. Lander, G. Getz (2013)
Mutational heterogeneity in cancer and the search for new cancer genesNature, 499
M. Narita, T. Kanda, T. Abe, T. Uchiyama, M. Iwafuchi, Zhiyin Zheng, Aichun Liu, Tsutomu Kaifu, S. Kosugi, M. Minagawa, K. Itoh, Masuhiro Takahashi (2015)
Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine.International journal of oncology, 46 4
PL Lorenzi, S Claerhout, GB Mills, JN Weinstein (2014)
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapyAutophagy, 10
Zhuhong You, Zhi-an Huang, Zexuan Zhu, Guiying Yan, Zhengwei Li, Zhenkun Wen, Xing Chen (2017)
PBMDA: A novel and effective path-based computational model for miRNA-disease association predictionPLoS Computational Biology, 13
Yulin Sun, Ni Shi, Haizhen Lu, Jinqiang Zhang, Yulong Ma, Y. Qiao, Y. Mao, Kun Jia, Lifen Han, Fang Liu, Hongxia Li, Zhengwei Lin, Xinmin Li, Xiaohang Zhao (2014)
ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.Carcinogenesis, 35 9
Junichi Hiratsuka, A. Kodama, Y. Imajo, O. Munemori, S. Imai, S. Nishishita, T. Shirabe, S. Watanabe, Y. Matsuo (1988)
[A case of triple cancer--gastric, esophageal and hepatocellular carcinoma].Gan no rinsho. Japan journal of cancer clinics, 34 6
Qifeng Wang, Hongxia Zhu, Z. Xiao, Wencheng Zhang, Xiao Liu, Xun Zhang, Jie He, K. Sun, Lvhua Wang, N. Xu (2013)
Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinomaWorld Journal of Surgical Oncology, 11
P. Lorenzi, S. Claerhout, G. Mills, J. Weinstein (2014)
A curated census of autophagy-modulating proteins and small moleculesAutophagy, 10
Xing Chen, Li Huang, Di Xie, Qi Zhao (2018)
EGBMMDA: Extreme Gradient Boosting Machine for MiRNA-Disease Association predictionCell Death & Disease, 9
Mikiko Takikita, N. Hu, J. Shou, Quan-hong Wang, C. Giffen, P. Taylor, S. Hewitt (2009)
Biomarkers of apoptosis and survival in esophageal squamous cell carcinomaBMC Cancer, 9
K. Lam, S. Tsao, Dekai Zhang, S. Law, Dan He, Lily Ma, J. Wong (1997)
Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patientsInternational Journal of Cancer, 74
L. Fu, Yan Qin, D. Xie, H. Chow, S. Ngai, D. Kwong, Yan Li, X. Guan (2007)
Identification of alpha‐actinin 4 and 67 kDa laminin receptor as stage‐specific markers in esophageal cancer via proteomic approachesCancer, 110
Sohaib Abu-Farsakh, Tongtong Wu, Amy LaLonde, Jun Sun, Zhongren Zhou (2017)
High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5BMC Gastroenterology, 17
Xing Chen, C. Yan, Xu Zhang, Zhuhong You (2016)
Long non-coding RNAs and complex diseases: from experimental results to computational modelsBriefings in Bioinformatics, 18
M. Roth, Shu-Fan Liu, S. Dawsey, B. Zhou, C. Copeland, Guo-qing Wang, D. Solomon, S. Baker, C. Giffen, P. Taylor (1997)
Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, ChinaCancer, 80
D. Donoho, Yaakov Tsaig (2008)
Fast Solution of $\ell _{1}$ -Norm Minimization Problems When the Solution May Be SparseIEEE Transactions on Information Theory, 54
S. Ohashi, S. Miyamoto, Osamu Kikuchi, T. Goto, Y. Amanuma, M. Muto (2015)
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.Gastroenterology, 149 7
K. Kaneko, T. Yano, K. Minashi, T. Kojima, Miki Ito, H. Satake, Y. Yajima, Y. Yoda, H. Ikematsu, Y. Oono, R. Hayashi, M. Onozawa, A. Ohtsu (2012)
Treatment Strategy for Superficial Pharyngeal Squamous Cell Carcinoma Synchronously Combined with Esophageal CancerOncology, 84
Xing Chen, Li Huang (2017)
LRSSLMDA: Laplacian Regularized Sparse Subspace Learning for MiRNA-Disease Association predictionPLoS Computational Biology, 13
H. Hara, M. Tahara, H. Daiko, Ken Kato, H. Igaki, S. Kadowaki, Yoichi Tanaka, Y. Hamamoto, H. Matsushita, M. Nagase, Y. Hosoya (2013)
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinomaCancer Science, 104
Yi-Fan Lu, D. Goldstein, M. Angrist, G. Cavalleri (2014)
Personalized medicine and human genetic diversity.Cold Spring Harbor perspectives in medicine, 4 9
Wencheng Zhang, Hongxia Zhu, Xiao Liu, Qifeng Wang, Xun Zhang, Jie He, K. Sun, Xiang-yang Liu, Zongmei Zhou, N. Xu, Z. Xiao (2014)
Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma.The Annals of thoracic surgery, 98 2
G. Davis, S. Mallat, M. Avellaneda (1997)
Adaptive greedy approximationsConstructive Approximation, 13
Xing Chen, Guiying Yan (2013)
Novel human lncRNA-disease association inference based on lncRNA expression profilesBioinformatics, 29 20
M. Rosenfeld, Laura Schramm, J.B Posner, J. Dalmau, N. Malats, M. Torà, Francisco Real, Francesc Graus, Nuria Viñolas, F. Cardenal, R. Rosell (1997)
Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer.Journal of the National Cancer Institute, 89 5
MS Lawrence, P Stojanov, P Polak (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genesNature, 499
Jianqiang Li, Zhi-Hao Rong, Xing Chen, Guiying Yan, Zhuhong You (2017)
MCMDA: Matrix completion for MiRNA-disease association predictionOncotarget, 8
Precision medicine and personalized treatment have attracted attention in recent years. However, most genetic medicines mainly target one genetic site, while complex diseases like esophageal squamous cell carcinoma (ESCC) usually present heterogeneity that involves variations of many genetic markers. Here, we seek an approach to leverage genetic data and ESCC knowledge data to forward personalized diagnosis and treatment for ESCC. First, 851 ESCC-related gene markers and their druggability were studied through a comprehensive literature analysis. Then, a sparse representation-based variable selection (SRVS) was employed for patient-specific genetic marker selection using gene expression datasets. Results showed that the SRVS method could identify a unique gene vector for each patient group, leading to significantly higher classification accuracies compared to randomly selected genes (100, 97.17, 100, 100%; permutation p values: 0.0032, 0.0008, 0.0004, and 0.0008). The SRVS also outperformed an ANOVA-based gene selection method in terms of the classification ratio. The patient-specific gene markers are targets of ESCC effective drugs, providing specific guidance for medicine selection. Our results suggest the effectiveness of integrating previous database utilizing SRVS in assisting personalized medicine selection and treatment for ESCC.
Bulletin of Mathematical Biology – Springer Journals
Published: Jun 4, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.